Takahashi N - Search Results

1

Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study.

Doi M, Takahashi N, Nojiri R, Hiraoka T, Kishimoto Y, Inoue S, Oya N. Doi M, et al. Among authors: takahashi n. J Intensive Care. 2023 Nov 13;11(1):51. doi: 10.1186/s40560-023-00698-9. J Intensive Care. 2023. PMID: 37953283 Free PMC article.

2

Age-Specific Dose Regimens of Dexmedetomidine for Pediatric Patients in Intensive Care Following Elective Surgery: A Phase 3, Multicenter, Open-Label Clinical Trial in Japan.

Takeuchi M, Nemoto S, Suzuki Y, Takahashi N, Takenaka N, Takata A, Kobayashi M. Takeuchi M, et al. Among authors: takahashi n. Pediatr Crit Care Med. 2021 Nov 1;22(11):e546-e557. doi: 10.1097/PCC.0000000000002730. Pediatr Crit Care Med. 2021. PMID: 33813550 Free PMC article.

3

The pharmacokinetics and safety profiles of belimumab after single subcutaneous and intravenous doses in healthy Japanese volunteers.

Shida Y, Takahashi N, Sakamoto T, Ino H, Endo A, Hirama T. Shida Y, et al. Among authors: takahashi n. J Clin Pharm Ther. 2014 Feb;39(1):97-101. doi: 10.1111/jcpt.12101. Epub 2013 Oct 5. J Clin Pharm Ther. 2014. PMID: 24117862 Clinical Trial.

4

Safety, tolerability, pharmacokinetics and pharmacodynamics of belimumab in Japanese patients with mild-to-moderate systemic lupus erythematosus.

Yamada M, Akita M, Nakagawa T, Takahashi N, Endo A, Yoshida P. Yamada M, et al. Among authors: takahashi n. J Drug Assess. 2013 Apr 12;2(1):40-8. doi: 10.3109/21556660.2013.792823. eCollection 2013. J Drug Assess. 2013. PMID: 27536436 Free PMC article.

5

Safety, tolerability, pharmacokinetics, and pharmacodynamics of losmapimod in healthy Japanese volunteers.

Ino H, Takahashi N, Terao T, Igarashi H, Sarai N. Ino H, et al. Among authors: takahashi n. Clin Pharmacol Drug Dev. 2015 Jul;4(4):262-9. doi: 10.1002/cpdd.190. Epub 2015 May 7. Clin Pharmacol Drug Dev. 2015. PMID: 27136906 Clinical Trial.

6

Pharmacokinetics, pharmacodynamics and safety of single, oral doses of GSK1278863, a novel HIF-prolyl hydroxylase inhibitor, in healthy Japanese and Caucasian subjects.

Hara K, Takahashi N, Wakamatsu A, Caltabiano S. Hara K, et al. Among authors: takahashi n. Drug Metab Pharmacokinet. 2015 Dec;30(6):410-8. doi: 10.1016/j.dmpk.2015.08.004. Epub 2015 Aug 28. Drug Metab Pharmacokinet. 2015. PMID: 26643993 Clinical Trial.

7

Pharmacokinetics, safety, and tolerability following single-dose migalastat hydrochloride (GR181413A/AT1001) in healthy male Japanese subjects.

Ino H, Takahashi N, Terao T, Mudd PN Jr, Hirama T. Ino H, et al. Among authors: takahashi n. J Drug Assess. 2013 Jul 24;2(1):87-93. doi: 10.3109/21556660.2013.827117. eCollection 2013. J Drug Assess. 2013. PMID: 27536442 Free PMC article.

8

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin 5 monoclonal antibody, in healthy Japanese male subjects.

Tsukamoto N, Takahashi N, Itoh H, Pouliquen I. Tsukamoto N, et al. Among authors: takahashi n. Clin Pharmacol Drug Dev. 2016 Mar;5(2):102-8. doi: 10.1002/cpdd.205. Epub 2015 Aug 18. Clin Pharmacol Drug Dev. 2016. PMID: 27138023 Free PMC article. Clinical Trial.

9

RIPK1 protects naive and regulatory T cells from TNFR1-induced apoptosis.

Huysentruyt J, Steels W, Ruiz Perez M, Verstraeten B, Vadi M, Divert T, Flies K, Takahashi N, Lambrecht BN, Declercq W, Vanden Berghe T, Maelfait J, Vandenabeele P, Tougaard P. Huysentruyt J, et al. Among authors: takahashi n. Cell Death Differ. 2024 May 11. doi: 10.1038/s41418-024-01301-w. Online ahead of print. Cell Death Differ. 2024. PMID: 38734851

10

Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.

Bucci T, Romiti GF, Corica B, Shantsila A, Teo WS, Park HW, Shimizu W, Tse HF, Proietti M, Chao TF, Lip GYH; Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. Bucci T, et al. Minerva Med. 2024 May 9. doi: 10.23736/S0026-4806.24.09159-6. Online ahead of print. Minerva Med. 2024. PMID: 38727706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,995 results

Search Page